Copyright Reports & Markets. All rights reserved.

Global Shingles Treatments Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Shingles Treatments Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral
      • 1.4.3 Tablets
    • 1.5 Market by Application
      • 1.5.1 Global Shingles Treatments Market Share by Application (2014-2025)
      • 1.5.2 Clinics
      • 1.5.3 Hospitals
      • 1.5.4 Diagnostic Centres
      • 1.5.5 Home Care Settings
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Shingles Treatments Market Size
    • 2.2 Shingles Treatments Growth Trends by Regions
      • 2.2.1 Shingles Treatments Market Size by Regions (2014-2025)
      • 2.2.2 Shingles Treatments Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Shingles Treatments Market Size by Manufacturers
      • 3.1.1 Global Shingles Treatments Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Shingles Treatments Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Shingles Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2 Shingles Treatments Key Players Head office and Area Served
    • 3.3 Key Players Shingles Treatments Product/Solution/Service
    • 3.4 Date of Enter into Shingles Treatments Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Shingles Treatments Market Size by Type (2014-2019)
    • 4.2 Global Shingles Treatments Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Shingles Treatments Market Size (2014-2019)
    • 5.2 Shingles Treatments Key Players in United States
    • 5.3 United States Shingles Treatments Market Size by Type
    • 5.4 United States Shingles Treatments Market Size by Application

    6 Europe

    • 6.1 Europe Shingles Treatments Market Size (2014-2019)
    • 6.2 Shingles Treatments Key Players in Europe
    • 6.3 Europe Shingles Treatments Market Size by Type
    • 6.4 Europe Shingles Treatments Market Size by Application

    7 China

    • 7.1 China Shingles Treatments Market Size (2014-2019)
    • 7.2 Shingles Treatments Key Players in China
    • 7.3 China Shingles Treatments Market Size by Type
    • 7.4 China Shingles Treatments Market Size by Application

    8 Japan

    • 8.1 Japan Shingles Treatments Market Size (2014-2019)
    • 8.2 Shingles Treatments Key Players in Japan
    • 8.3 Japan Shingles Treatments Market Size by Type
    • 8.4 Japan Shingles Treatments Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Shingles Treatments Market Size (2014-2019)
    • 9.2 Shingles Treatments Key Players in Southeast Asia
    • 9.3 Southeast Asia Shingles Treatments Market Size by Type
    • 9.4 Southeast Asia Shingles Treatments Market Size by Application

    10 India

    • 10.1 India Shingles Treatments Market Size (2014-2019)
    • 10.2 Shingles Treatments Key Players in India
    • 10.3 India Shingles Treatments Market Size by Type
    • 10.4 India Shingles Treatments Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Shingles Treatments Market Size (2014-2019)
    • 11.2 Shingles Treatments Key Players in Central & South America
    • 11.3 Central & South America Shingles Treatments Market Size by Type
    • 11.4 Central & South America Shingles Treatments Market Size by Application

    12 International Players Profiles

    • 12.1 Astellas Pharma
      • 12.1.1 Astellas Pharma Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Shingles Treatments Introduction
      • 12.1.4 Astellas Pharma Revenue in Shingles Treatments Business (2014-2019)
      • 12.1.5 Astellas Pharma Recent Development
    • 12.2 Foamix
      • 12.2.1 Foamix Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Shingles Treatments Introduction
      • 12.2.4 Foamix Revenue in Shingles Treatments Business (2014-2019)
      • 12.2.5 Foamix Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Shingles Treatments Introduction
      • 12.3.4 Novartis Revenue in Shingles Treatments Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Roche
      • 12.4.1 Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Shingles Treatments Introduction
      • 12.4.4 Roche Revenue in Shingles Treatments Business (2014-2019)
      • 12.4.5 Roche Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Shingles Treatments Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Shingles Treatments Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Epiphany Biosciences
      • 12.6.1 Epiphany Biosciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Shingles Treatments Introduction
      • 12.6.4 Epiphany Biosciences Revenue in Shingles Treatments Business (2014-2019)
      • 12.6.5 Epiphany Biosciences Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Shingles Treatments Introduction
      • 12.7.4 Merck Revenue in Shingles Treatments Business (2014-2019)
      • 12.7.5 Merck Recent Development
    • 12.8 Beijing Minhai Biotechnology
      • 12.8.1 Beijing Minhai Biotechnology Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Shingles Treatments Introduction
      • 12.8.4 Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2014-2019)
      • 12.8.5 Beijing Minhai Biotechnology Recent Development
    • 12.9 GeneOne Life Science
      • 12.9.1 GeneOne Life Science Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Shingles Treatments Introduction
      • 12.9.4 GeneOne Life Science Revenue in Shingles Treatments Business (2014-2019)
      • 12.9.5 GeneOne Life Science Recent Development
    • 12.10 NAL Pharmaceuticals
      • 12.10.1 NAL Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Shingles Treatments Introduction
      • 12.10.4 NAL Pharmaceuticals Revenue in Shingles Treatments Business (2014-2019)
      • 12.10.5 NAL Pharmaceuticals Recent Development
    • 12.11 TSRL

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area.
      The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles.
      In 2018, the global Shingles Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Shingles Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Shingles Treatments development in United States, Europe and China.

      The key players covered in this study
      Astellas Pharma
      Foamix
      Novartis
      Roche
      GlaxoSmithKline
      Epiphany Biosciences
      Merck
      Beijing Minhai Biotechnology
      GeneOne Life Science
      NAL Pharmaceuticals
      TSRL

      Market segment by Type, the product can be split into
      Oral
      Tablets

      Market segment by Application, split into
      Clinics
      Hospitals
      Diagnostic Centres
      Home Care Settings

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Shingles Treatments status, future forecast, growth opportunity, key market and key players.
      To present the Shingles Treatments development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Shingles Treatments are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now